For COVID, Consensus On Value Of Platform Trials, But A Confusion Of Consortia

 
• By Bridget Silverman
Image of business partners hands on top of each other symbolizing companionship and unity
Master protocols are a cornerstone of the “critical path” for COVID-19 therapeutics proposed by a recent Duke-Margolis Center paper. • Source: Shutterstock

More from Clinical Trials

More from R&D